Drug Profile
Research programme: type 1 diabetes vaccine - Vaxine
Latest Information Update: 20 Apr 2010
Price :
$50
*
At a glance
- Originator Vaxine
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 27 Nov 2006 Vaxine is seeking development partners for the type 1 diabetes vaccine candidate
- 27 Nov 2006 Preclinical trials in Diabetes mellitus in Australia (Injection)